The Alzheimer’s Dilemma: Government and Private Payers Must Evolve or Die

Mar 20, 2023

By MacKay Jimeson In a proclamation last year, President Joe Biden said, “in the next 30 years, the number of Americans with Alzheimer’s is expected to reach nearly 14 million, straining families and our health care system. Fortunately, we are on the cusp of...

This Rare Disease Day we need to go beyond raising awareness and move towards tangible policy and regulatory action.

Feb 28, 2023

By MacKay Jimeson Too many patients and families are in crisis as we mark another Rare Disease Day. Policymakers are focused on debates on Accelerated Approval and drug pricing, while many patients are without treatment due to regulatory or insurance coverage...

PRESS RELEASE: Patient Group Releases Special Report on Biosimilar Market and Trends

Jan 25, 2023

New report analyzes patient impact of game-changing biosimilars, including the introduction of competing biosimilars for Humira WASHINGTON — Patients Rising, a non-profit organization advocating on behalf of patients with chronic and rare diseases, today released its...

ICER’s Latest: A draft evidence report on treatments for vasomotor symptoms of menopause

Oct 20, 2022

Op-Ed: Medicare’s cuts to home health are a step in the wrong direction

Oct 12, 2022

By Terry WilcoxCo-founder and CEO, Patients Rising My grandmother lived at the top of a hill overlooking the magical mountains and valleys of the Ozarks until the day we literally had to drag her off of it. Our family was spread out across Texas and California working...